Are there specific blood tests for fibromyalgia or CFS? 

In the United Kingdom, there is currently no single, definitive blood test used by the NHS to diagnose fibromyalgia or chronic fatigue syndrome (ME/CFS). Diagnosis is primarily a clinical process based on a person’s medical history, the presence of specific symptoms over time, and the exclusion of other illnesses. However, blood tests are an essential part of the diagnostic journey. They are used to rule out other medical conditions that cause similar symptoms, such as anaemia, thyroid problems, or autoimmune diseases, to ensure the correct diagnosis is reached. 

What We’ll Discuss in This Article 

• Why there is currently no standard diagnostic test for these conditions 

• The routine blood tests ordered by UK GPs to rule out other illnesses 

• The role of inflammatory markers in the diagnostic process 

• Recent research into potential new “fingerprint” blood tests 

• Why “normal” test results are common in fibromyalgia and ME/CFS 

• How doctors use clinical criteria alongside lab results 

The role of blood tests in the UK diagnostic process 

When a patient presents with widespread pain or chronic exhaustion, a GP’s first task is to ensure these symptoms are not being caused by a treatable underlying condition. Because fibromyalgia and ME/CFS are considered “diagnoses of exclusion,” blood tests are used to check for a wide range of alternative health problems. If these tests come back within the normal range, it increases the likelihood that fibromyalgia or ME/CFS is the correct diagnosis. 

According to NHS guidance on fibromyalgia, doctors look for signs of other conditions like arthritis or an underactive thyroid. If your blood tests are normal but you still experience persistent, widespread pain and fatigue for at least three months, your GP will then apply the clinical diagnostic criteria. These criteria focus on the location of your pain, the severity of your fatigue, and the impact of cognitive symptoms rather than a laboratory result. 

In the case of ME/CFS, the NICE guidelines specify that a diagnosis should be suspected if the four core symptoms (debilitating fatigue, post-exertional malaise, unrefreshing sleep, and brain fog) are present and other causes have been investigated. Blood tests are a mandatory part of this investigation to ensure that the patient’s fatigue is not caused by a simple deficiency or a more serious systemic illness. 

Routine blood tests ordered by the NHS 

Your GP will typically order a standard set of blood tests to assess your general health and rule out common mimics of chronic fatigue and pain. These tests are the same for almost all patients in the UK experiencing these symptoms. 

The common tests include: 

• Full Blood Count (FBC): To check for anaemia (low iron) or signs of an active infection. 

• Thyroid Function Tests (TFTs): To rule out an underactive thyroid (hypothyroidism), which can cause profound fatigue and muscle aches. 

• Kidney and Liver Function Tests: To ensure your organs are filtering waste correctly and that there is no underlying metabolic issue. 

• Blood Glucose (HbA1c): To check for diabetes, which can cause significant tiredness. 

• Vitamin D, B12, and Folate: Deficiencies in these vitamins are extremely common in the UK and can cause muscle pain, weakness, and “brain fog.” 

If these results are normal, it does not mean your pain or fatigue is not real; it simply means the cause is likely a functional condition like fibromyalgia or ME/CFS rather than a structural or nutritional one. 

Checking for inflammation and autoimmune markers 

A key part of the diagnostic process is distinguishing fibromyalgia from inflammatory conditions like rheumatoid arthritis or lupus. While fibromyalgia causes intense pain, it does not cause inflammation in the tissues or joints. Therefore, markers of inflammation in the blood are usually normal in people with fibromyalgia. 

GPs will often check for: 

• C-Reactive Protein (CRP) and Erythrocyte Sedimentation Rate (ESR): These tests measure the level of inflammation in the body. In fibromyalgia and ME/CFS, these are typically low or normal. 

• Antinuclear Antibody (ANA) and Rheumatoid Factor (RF): These are used if the doctor suspects an autoimmune disease. While these can sometimes be slightly elevated in healthy people, a negative result helps rule out conditions that involve the immune system attacking the body’s own joints. 

If these tests show significant inflammation, your GP may refer you to a rheumatologist to investigate for arthritis. However, the Royal College of General Practitioners notes that it is possible to have an inflammatory condition and fibromyalgia at the same time, which requires a carefully balanced management plan. 

Recent breakthroughs in diagnostic research 

While there is no standard test today, researchers in the UK have made significant progress toward developing a specific blood test for ME/CFS. In late 2025 and early 2026, scientists at the University of East Anglia (UEA) and Oxford BioDynamics announced the development of a high-accuracy blood test for ME/CFS. This test uses advanced “3D genomics” technology to identify a specific biological fingerprint in how a person’s DNA is folded. 

This new test, often called the EpiSwitch CFS test, has shown a 96% accuracy rate in early studies in identifying people with the condition. It looks beyond traditional blood markers to see how genes are being switched on or off by the disease. While this test is a revolutionary step forward and provides biological validation for patients, it is not yet a routine part of every GP’s diagnostic toolkit across the entire NHS. It represents the future of how these complex conditions may be diagnosed and managed. 

In the field of fibromyalgia, researchers are also exploring tests like the FM/a test, which looks at immune system markers called cytokines. While these are promising and are being used in some private settings or clinical trials, they are not yet recommended for standard use by NICE or the NHS until more long-term data is available. 

Why “normal” results can be frustrating 

For many patients, receiving “normal” blood test results after months of debilitating pain and fatigue can be extremely frustrating. It can feel as though the doctor is suggesting nothing is wrong. However, in the context of fibromyalgia and ME/CFS, a normal blood test is actually a piece of diagnostic evidence. It confirms that the symptoms are not being caused by inflammation, organ damage, or a deficiency. 

It is important to remember that fibromyalgia is a condition of the nervous system; it is a problem with the body’s “software” rather than its “hardware.” Just as a computer may have a software crash that doesn’t show up on a hardware scan, fibromyalgia symptoms do not show up on tests designed to find physical damage. Validation comes from the clinical assessment of your symptoms and the impact they have on your life. 

If your tests are normal, this is the point at which your GP should start discussing a diagnosis of fibromyalgia or ME/CFS, provided you meet the symptom criteria. You may wish to ask your GP for a copy of your results so you can see exactly what has been ruled out. 

Conclusion 

There is currently no specific, routine blood test used by the NHS to diagnose fibromyalgia or ME/CFS. Instead, blood tests are used to rule out other medical conditions with similar symptoms. While recent research has unveiled promising new “fingerprint” tests with high accuracy, these are not yet standard across all UK primary care settings. Diagnosis remains a clinical process based on your symptoms and their duration. If your blood tests are normal but your pain and fatigue persist, this is a valid clinical finding that supports a diagnosis of fibromyalgia or ME/CFS. 

If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T Block) 

This article provides an evidence-based overview of the role of blood testing in the diagnosis of fibromyalgia and ME/CFS in the UK. It was prepared by the MyPatientAdvice team and reviewed by Dr. Stefan Petrov to ensure alignment with the latest NHS and NICE clinical guidance, including recent research breakthroughs. The purpose of this content is to help patients understand the necessity and limitations of lab work in chronic illness diagnosis.